Clinical Trial

Virtual tES Device Treatment for Parkinson's Disease Motor Symptoms

Recruiting Phase 1/2
View on ClinicalTrials.gov →
Record status
This record was last updated January 27, 2026 (before its estimated March 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study tests a new, non-invasive brain stimulation device called Sphere V3.0 to help improve movement problems in people with Parkinson's disease. The device delivers gentle electrical signals to the scalp using small electrodes placed on the head. Participants will use the device at home for 13 minutes each weekday (Monday through Friday) for 3 weeks, then be monitored for another 3 weeks without treatment. The entire study lasts 6 weeks and is conducted virtually through video calls and online assessments. The investigators will measure changes in Parkinson's symptoms using standard rating scales and video recordings of movement tasks like walking and hand tremor tests. Participants will also record videos of their movements at home using their smartphone or computer. The study includes 30 adults aged 18-80 who have been diagnosed with Parkinson's disease and have stable medication for at least 4 weeks. Participants must have reliable internet access and be able to follow the treatment schedule. The main goal is to see if this brain stimulation treatment can reduce motor symptoms like tremor, stiffness, and slowness of movement. The investigators will also check if any improvements last after treatment ends and monitor for any side effects. All participants receive the active device treatment - there is no placebo group. The device has been tested in over 250 people in previous studies with no serious adverse events reported
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-09-16; most recent amendment 2026-01-23.
Status change: Not Yet Recruiting → Recruiting 2026-01-23
Trial Details
NCT Number NCT07182058
Lead Sponsor U: The Mind Company
Conditions PARKINSON DISEASE (Disorder)
Enrollment 30 participants
Start Date 2026-01-01
Primary Completion 2026-03-01 (estimated)
Study Completion 2026-04-01 (estimated)
Updated on ClinicalTrials.gov 2026-01-27